- Featured Product
- KD/KO Validated
BCL3 Polyklonaler Antikörper
BCL3 Polyklonal Antikörper für WB, IHC, IF/ICC, IP, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus
Anwendung
WB, IHC, IF/ICC, IP, Indirect ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 23959-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
23959-1-PBS bindet in WB, IHC, IF/ICC, IP, Indirect ELISA BCL3 und zeigt Reaktivität mit human, Maus
| Getestete Reaktivität | human, Maus |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | BCL3 fusion protein Ag21040 |
| Vollständiger Name | B-cell CLL/lymphoma 3 |
| Berechnetes Molekulargewicht | 446 aa, 47 kDa |
| Beobachtetes Molekulargewicht | 48-60 kDa |
| GenBank-Zugangsnummer | BC064993 |
| Gene symbol | BCL3 |
| Gene ID (NCBI) | 602 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
BCL3 (B-cell lymphoma 3 protein) has seven ankyrin repeat domains, a proline-rich N terminal domain and a serine- and proline-rich C-terminal domain(PMID: 31930327). BCL3 is an important contributor to chronic inflammatory disease states, such as osteoarthritis and rheumatoid arthritis (PMID: 12483727). BCL3 is a predominantly nuclear protein containing a trans-activation domain, and it can be recruited to NF-κB-responsive promoters, resulting in transcriptional activation or repression depending on the subunit composition of NF-κB complexes (PMID: 25089799, PMID: 30135206). BCL3 is known to be overexpressed in human breast cancers and is associated with reduced metastasis-free survival (PMID: 38255248).



























